Deep Medicine Acquisition Corp. – NASDAQ:DMAQR

Financial Health
0
1
2
3
4
5
6
7
8
9

Deep Medicine Acquisition Corp. stock price monthly change

-16.67%
month

Deep Medicine Acquisition Corp. stock price quarterly change

-26.47%
quarter

Deep Medicine Acquisition Corp. stock price yearly change

+150.25%
year

Deep Medicine Acquisition Corp. key metrics

Market Cap
 1.08M
Enterprise value
 N/A
P/E
 N/A
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 -0.48
Revenue
 N/A
EBITDA
 -2.06M
Income
 -1.54M
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Deep Medicine Acquisition Corp. stock price history

Deep Medicine Acquisition Corp. stock forecast

Deep Medicine Acquisition Corp. financial statements

Profit Margin

Deep Medicine Acquisition Corp. (NASDAQ:DMAQR): Profit margin
Mar 2023 90K -657.60K -730.67%
Jun 2023 0 -261.56K
Sep 2023 0 -270.34K
Dec 2023 0 -359.95K
DMAQR income statement history
0%
Yield TTM
Deep Medicine Acquisition Corp. (NASDAQ:DMAQR): Payout ratio
Payout ratio 0%
Deep Medicine Acquisition Corp. (NASDAQ:DMAQR): Dividend Yield
2021 0.26%
2022 1.4%
2023
DMAQR dividends history

Debt to Assets

Deep Medicine Acquisition Corp. (NASDAQ:DMAQR): Debt to assets
Dec 2022 10008855 6.79M 67.91%
Jun 2023 10013371 7.72M 77.1%
Sep 2023 7005273 7.89M 112.73%
Dec 2023 6881206 8.13M 118.19%
DMAQR balance sheet history

Cash Flow

Deep Medicine Acquisition Corp. (NASDAQ:DMAQR): Cash Flow
Mar 2023 -366.64K 120.93M -120.93M
Jun 2023 -53.50K -200K 200K
Sep 2023 -269.17K 2.91M -2.82M
Dec 2023 577.35K 0 12.50M
DMAQR cash flow history

Deep Medicine Acquisition Corp. other data

Deep Medicine Acquisition Corp.
Hedge Funds Holdings Q1 2023

100.00% 0.00%
of DMAQR is owned by hedge funds
9 -19
hedge funds hold DMAQR stock
3.72M -6.14M
shares is hold by hedge funds
DMAQR hedge funds holdings changes

Frequently Asked Questions (FAQ)

  • When is Deep Medicine Acquisition Corp.'s next earnings date?

    Unfortunately, Deep Medicine Acquisition Corp.'s (DMAQR) next earnings date is currently unknown.

  • Does Deep Medicine Acquisition Corp. pay dividends?

    No, Deep Medicine Acquisition Corp. does not pay dividends.

  • How much money does Deep Medicine Acquisition Corp. make?

    Deep Medicine Acquisition Corp. has a market capitalization of 1.08M.

  • What is Deep Medicine Acquisition Corp.'s stock symbol?

    Deep Medicine Acquisition Corp. is traded on the NASDAQ under the ticker symbol "DMAQR".

  • What is Deep Medicine Acquisition Corp.'s primary industry?

    Company operates in the Financial Services sector and Shell Companies industry.

  • How do i buy shares of Deep Medicine Acquisition Corp.?

    Shares of Deep Medicine Acquisition Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • When Deep Medicine Acquisition Corp. went public?

    Deep Medicine Acquisition Corp. is publicly traded company for more then 3 years since IPO on 2 Dec 2021.

  • Where are Deep Medicine Acquisition Corp.'s headquarters?

    Deep Medicine Acquisition Corp. is headquartered at 595 Madison Avenue, New York, NY.

  • How can i contact Deep Medicine Acquisition Corp.?

    Deep Medicine Acquisition Corp.'s mailing address is 595 Madison Avenue, New York, NY and company can be reached via phone at +91 72892776.

Deep Medicine Acquisition Corp. company profile:

Deep Medicine Acquisition Corp.

Exchange:

NASDAQ

Full time employees:

0

Industry:

Shell Companies

Sector:

Financial Services

Deep Medicine Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on identifying businesses in the healthcare industry. The company was incorporated in 2020 and is based in New York, New York.

+91 72892776
595 Madison Avenue
New York, NY 10017

CIK: 0001857086
ISIN: US2437331109
CUSIP: 243733110